Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gag protein of HIV-1 is a polyprotein essential for the late phase of the viral life cycle, including assembly, budding, and maturation. It drives auto-assembly at the plasma membrane, orchestrates encapsidation of genomic RNA, interacts with host cell proteins, and is cleaved by HIV protease into mature structural proteins. Gag is a promising target for future antiretroviral therapies aimed at disrupting viral assembly and budding.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gag Protein of Human Immunodeficiency Virus Type 1 (Gag).